Literature DB >> 15077093

Evaluation of atrial refractoriness immediately after percutaneous mitral balloon commissurotomy in patients with mitral stenosis and sinus rhythm.

Mustafa Soylu1, Ahmet Duran Demir, Ozcan Ozdemir, Serkan Topaloğlu, Dursun Aras, Erdal Duru, Ali Saşmaz, Sule Korkmaz.   

Abstract

BACKGROUND: Chronic atrial stretch and rheumatic inflammatory activity leads to atrial dilatation and conduction slowing, and this increases the susceptibility to atrial fibrillation (AF). The aim of this study was to examine the effects of changes in the chronic atrial stretch on atrial refractoriness in the early period after percutaneous mitral balloon commissurotomy (PMBC) in patients with mitral stenosis and sinus rhythm.
METHODS: Twenty-five patients undergoing PMBC were enrolled in this study. We evaluated the changes in pulmonary arterial pressure (PAP), left atrial (LA) pressure, mean mitral diastolic gradient, and mitral valve area in addition to the changes in atrial effective refractory periods (AERPs), AERP dispersion, and intra-atrial and interatrial conduction times after PMBC.
RESULTS: There were significant decreases in mean diastolic gradient, PAP, mean LA pressure, and LA size after PMBC. Accompanying these acute hemodynamic changes after PMBC, AERPs in high right atrium (HRA), distal coronary sinus (DCS), and right posterolateral (RPL) were found to be increased (P <.001), and AERP dispersion, PA(HIS) (an interval between P wave on the surface electrocardiogram and atrial electrogram at the His bundle site), and HRA-DCS intervals were significantly reduced after PMBC (P <.001). It was revealed with linear regression and correlation analysis that only the changes in AERP dispersion were correlated with changes in LA pressure.
CONCLUSIONS: Relief of chronic atrial stretch results in an increase in AERPs and decrease in AERP dispersion, suggesting the potential reversibility of the electrophysiological features of chronic atrial dilatation. Our study emphasizes that an acute reduction of chronic atrial stretch in mitral stenosis resulted in favorable effects on atrial electrophysiological characteristics, and our results provide the first detailed insights into the electrophysiological changes after PMBC in patients with sinus rhythm.

Entities:  

Mesh:

Year:  2004        PMID: 15077093     DOI: 10.1016/j.ahj.2003.10.027

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  6 in total

1.  The value of rhythm control in mitral stenosis.

Authors:  G Karthikeyan
Journal:  Heart       Date:  2006-08       Impact factor: 5.994

Review 2.  Impact of Atrial Fibrillation On Cardiovascular Mortality in the Setting of Myocardial Infarction.

Authors:  Mahmoud Suleiman; Doron Aranson
Journal:  J Atr Fibrillation       Date:  2012-12-16

3.  The acute effect of percutaneous mitral balloon valvuloplasty on atrial electromechanical delay and P-wave dispersion in patients with mitral stenosis.

Authors:  B Demirkan; Y Guray; U Guray; M R Ege; H L Kisacik; H Sasmaz; S Korkmaz
Journal:  Herz       Date:  2012-09-08       Impact factor: 1.443

4.  Electrocardiographic P-wave Indices as a Useful Tool to Predict Successful Percutaneous Balloon Mitral Valvotomy in Patients with Mitral Stenosis.

Authors:  Babak Kazemi; Ali Rostami; Naser Aslanabadi; Samad Ghaffari
Journal:  J Cardiovasc Thorac Res       Date:  2014-03-21

5.  Usefulness of the Macruz Index for Predicting Successful Percutaneous Mitral Balloon Valvuloplasty in Patients with Mitral Stenosis.

Authors:  Kevser Gülcihan Balcı; Mustafa Mücahit Balcı; Orhan Maden; Fatih Şen; Mehmet Kadri Akboga; Burak Açar; Meryem Kara; Sadık Kadri Açıkgöz; Hatice Selcuk; Mehmet Timur Selcuk
Journal:  Med Princ Pract       Date:  2015-11-06       Impact factor: 1.927

6.  ECG changes after percutaneous edge-to-edge mitral valve repair.

Authors:  Hou Bo; David Heinzmann; Christian Grasshoff; Peter Rosenberger; Christian Schlensak; Meinrad Gawaz; Jürgen Schreieck; Harald F Langer; Johannes Patzelt; Peter Seizer
Journal:  Clin Cardiol       Date:  2019-09-09       Impact factor: 2.882

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.